Skip to content

SOLVUS: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SOLVUS

BE 0771.457.727
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€170,841
2024 · €862,295-€691,454
Equity
€406,905
2024 · €336,064+€70,841
Cash
€2.4m
2024 · €482,765+€1.9m
Balance sheet total
€2.5m
2024 · €1.4m+€1.1m

Largest movements

2024 to 2025
Assets
  • Cash +€1.9m

    up €1.9m (+391.1%), from €482,765 to €2.4m

    mainly Advances received (+€1.4m) and Receivables within one year (+€800,205)

  • Receivables within one year -€800,205

    down €800,205 (-86.4%), from €926,491 to €126,286

    of which Trade receivables: -€806,998

Equity and liabilities
  • Advances received +€1.4m

    up €1.4m (+2954.7%), from €46,026 to €1.4m

  • Short-term financial debts -€600,000

    down €600,000 (-100.0%), from €600,000 to €0

  • Accrued charges and deferred income +€198,156

    up €198,156 (+5260.2%), from €3,767 to €201,923

  • Reserves +€70,841

    up €70,841 (+21.3%), from €333,064 to €403,905

  • Trade debts +€26,852

    up €26,852 (+194.7%), from €13,795 to €40,646

Income statement
  • Financial income -€656,501

    down €656,501 (-99.8%), from €657,820 to €1,319

  • Staff costs +€109,078

    up €109,078 (+116.6%), from €93,555 to €202,632

  • Gross operating margin +€77,604

    up €77,604 (+18.7%), from €414,430 to €492,034

  • Financial charges +€12,201

    up €12,201 (+26.6%), from €45,836 to €58,036

  • Taxes -€10,041

    down €10,041 (-14.4%), from €69,729 to €59,689

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €862,295
Gross operating margin +€77,604
Staff costs -€109,078
Depreciation -€160
Other operating charges -€1,160
Financial income -€656,501
Financial charges -€12,201
Taxes +€10,041
Result 2025 €170,841

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€2.6m
Investment -€204
Financing -€700,000
Cash 2024 €482,765
Net result for the year +€170,841
Depreciation +€798
Receivables within one year +€800,205
Deferred charges and accrued income +€12,882
Trade debts +€26,852
Tax, wage and social debts +€18,874
Advances received +€1.4m
Accrued charges and deferred income +€198,156
Investment in fixed assets (net) -€204
Short-term financial debts -€600,000
Contributions, distributions and other -€100,000
Cash 2025 €2.4m
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,426,206 €2,500,854 +€1.1m +75.4%
Fixed assets 21/28 €1,385 €791 -€594 -42.9%
Tangible fixed assets 22/27 €1,385 €587 -€798 -57.6%
Plant, machinery and equipment 23 €1,385 €587 -€798 -57.6%
Financial fixed assets 28 - €204 +€204
Current assets 29/58 €1,424,821 €2,500,063 +€1.1m +75.5%
Amounts receivable within one year 40/41 €926,491 €126,286 -€800,205 -86.4%
Trade receivables 40 €925,426 €118,428 -€806,998 -87.2%
Other amounts receivable 41 €1,064 €7,858 +€6,793 +638.2%
Cash at bank and in hand 54/58 €482,765 €2,371,093 +€1.9m +391.1%
Deferred charges and accrued income 490/1 €15,566 €2,684 -€12,882 -82.8%
Total equity and liabilities 10/49 €1,426,206 €2,500,854 +€1.1m +75.4%
Equity 10/15 €336,064 €406,905 +€70,841 +21.1%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 €333,064 €403,905 +€70,841 +21.3%
Distributable reserves 133 €333,064 €403,905 +€70,841 +21.3%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €1,090,142 €2,093,949 +€1.0m +92.1%
Amounts payable within one year 42/48 €1,086,375 €1,892,026 +€805,651 +74.2%
Financial debts 43 €600,000 €0 -€600,000 -100.0%
Credit institutions 430/8 €600,000 €0 -€600,000 -100.0%
Trade debts 44 €13,795 €40,646 +€26,852 +194.7%
Suppliers 440/4 €13,795 €40,646 +€26,852 +194.7%
Advances received on contracts in progress 46 €46,026 €1,405,952 +€1.4m +2954.7%
Taxes, remuneration and social security 45 €72,554 €91,428 +€18,874 +26.0%
Taxes 450/3 €72,523 €78,060 +€5,536 +7.6%
Remuneration and social security 454/9 €31 €13,369 +€13,338 +42955.7%
Other amounts payable 47/48 €354,000 €354,000 = 0.0%
Accrued charges and deferred income 492/3 €3,767 €201,923 +€198,156 +5260.2%
Remuneration, social security and pensions 62 €93,555 €202,632 +€109,078 +116.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €638 €798 +€160 +25.0%
Other operating charges 640/8 €198 €1,358 +€1,160 +586.7%
Gross operating margin 9900 €414,430 €492,034 +€77,604 +18.7%
Operating profit (loss) 9901 €320,040 €287,247 -€32,793 -10.2%
Financial income 75/76B €657,820 €1,319 -€656,501 -99.8%
Recurring financial income 75 €657,820 €1,319 -€656,501 -99.8%
Financial charges 65/66B €45,836 €58,036 +€12,201 +26.6%
Recurring financial charges 65 €45,836 €58,036 +€12,201 +26.6%
Profit (loss) for the period before taxes 9903 €932,024 €230,529 -€701,495 -75.3%
Income taxes 67/77 €69,729 €59,689 -€10,041 -14.4%
Profit (loss) for the period 9904 €862,295 €170,841 -€691,454 -80.2%
Profit (loss) for the period to be appropriated 9905 €862,295 €170,841 -€691,454 -80.2%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.